Electromed (ELMD) Liabilities and Shareholders Equity (2011 - 2026)
Electromed (ELMD) reported Liabilities and Shareholders Equity of $59.5 million for Q1 2026, up 13.39% year-over-year from $52.5 million in Q1 2025, and up 8.31% quarter-over-quarter from $54.9 million in Q4 2025.
Electromed (ELMD) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Electromed (ELMD) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $59.5 million in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $59.5 million, up 13.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $221.8 million (up 7.74% YoY), and the FY2025 annual result was $53.8 million, up 3.0% from the prior year.
- Liabilities and Shareholders Equity grew to $59.5 million in Q1 2026 per ELMD's latest filing, from $54.9 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $59.5 million in Q1 2026 and troughed at $39.0 million in Q1 2022.
- A 5-year average of $48.1 million and a median of $48.9 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity rose 14.15% in 2024, then gained 3.0% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $41.4 million in 2022, then gained by 13.46% to $47.0 million in 2023, then rose by 11.31% to $52.3 million in 2024, then climbed by 5.04% to $54.9 million in 2025, then advanced by 8.31% to $59.5 million in 2026.
- Business Quant data shows ELMD's Liabilities and Shareholders Equity at $59.5 million in Q1 2026, $54.9 million in Q4 2025, and $53.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 6.63 Bn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 37.13 Bn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Electromed | 306.48 Mn | 289.50 Mn | 14.64 Mn | 59.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.47 Mn |
| Dec 31, 2025 | 54.91 Mn |
| Sep 30, 2025 | 53.61 Mn |
| Jun 30, 2025 | 53.80 Mn |
| Mar 31, 2025 | 52.45 Mn |
| Dec 31, 2024 | 52.27 Mn |
| Sep 30, 2024 | 48.92 Mn |
| Jun 30, 2024 | 52.23 Mn |
| Mar 31, 2024 | 48.90 Mn |
| Dec 31, 2023 | 46.96 Mn |
| Sep 30, 2023 | 44.07 Mn |
| Jun 30, 2023 | 45.81 Mn |
| Mar 31, 2023 | 42.84 Mn |
| Dec 31, 2022 | 41.39 Mn |
| Sep 30, 2022 | 40.13 Mn |
| Jun 30, 2022 | 41.36 Mn |
| Mar 31, 2022 | 39.02 Mn |
| Dec 31, 2021 | 38.20 Mn |
| Sep 30, 2021 | 37.90 Mn |
| Jun 30, 2021 | 37.11 Mn |